These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Oleic Acid Protects Endothelial Cells from Silica-Coated Superparamagnetic Iron Oxide Nanoparticles (SPIONs)-Induced Oxidative Stress and Cell Death. Repar N; Jovičić EJ; Kump A; Birarda G; Vaccari L; Erman A; Kralj S; Nemec S; Petan T; Drobne D Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806014 [TBL] [Abstract][Full Text] [Related]
23. Selection of potential iron oxide nanoparticles for breast cancer treatment based on in vitro cytotoxicity and cellular uptake. Poller JM; Zaloga J; Schreiber E; Unterweger H; Janko C; Radon P; Eberbeck D; Trahms L; Alexiou C; Friedrich RP Int J Nanomedicine; 2017; 12():3207-3220. PubMed ID: 28458541 [TBL] [Abstract][Full Text] [Related]
24. LHRH-conjugated magnetic iron oxide nanoparticles for detection of breast cancer metastases. Leuschner C; Kumar CS; Hansel W; Soboyejo W; Zhou J; Hormes J Breast Cancer Res Treat; 2006 Sep; 99(2):163-76. PubMed ID: 16752077 [TBL] [Abstract][Full Text] [Related]
25. Targeting experimental orthotopic glioblastoma with chitosan-based superparamagnetic iron oxide nanoparticles (CS-DX-SPIONs). Shevtsov M; Nikolaev B; Marchenko Y; Yakovleva L; Skvortsov N; Mazur A; Tolstoy P; Ryzhov V; Multhoff G Int J Nanomedicine; 2018; 13():1471-1482. PubMed ID: 29559776 [TBL] [Abstract][Full Text] [Related]
26. Shell matters: Magnetic targeting of SPIONs and in vitro effects on endothelial and monocytic cell function. Matuszak J; Dörfler P; Zaloga J; Unterweger H; Lyer S; Dietel B; Alexiou C; Cicha I Clin Hemorheol Microcirc; 2015; 61(2):259-77. PubMed ID: 26410877 [TBL] [Abstract][Full Text] [Related]
27. Biotechnological approach to induce human fibroblast apoptosis using superparamagnetic iron oxide nanoparticles. Ferraz FS; López JL; Lacerda SMSN; Procópio MS; Figueiredo AFA; Martins EMN; Guimarães PPG; Ladeira LO; Kitten GT; Dias FF; Domingues RZ; Costa GMJ J Inorg Biochem; 2020 May; 206():111017. PubMed ID: 32120160 [TBL] [Abstract][Full Text] [Related]
28. Superparamagnetic iron oxide nanoparticles conjugated with epidermal growth factor (SPION-EGF) for targeting brain tumors. Shevtsov MA; Nikolaev BP; Yakovleva LY; Marchenko YY; Dobrodumov AV; Mikhrina AL; Martynova MG; Bystrova OA; Yakovenko IV; Ischenko AM Int J Nanomedicine; 2014; 9():273-87. PubMed ID: 24421639 [TBL] [Abstract][Full Text] [Related]
29. Superparamagnetic Iron Oxide Nanoparticles Modified with Silica Layers as Potential Agents for Lung Cancer Treatment. Reczyńska K; Marszałek M; Zarzycki A; Reczyński W; Kornaus K; Pamuła E; Chrzanowski W Nanomaterials (Basel); 2020 May; 10(6):. PubMed ID: 32486431 [TBL] [Abstract][Full Text] [Related]
30. Delivery of Superparamagnetic Polymeric Micelles Loaded With Quercetin to Hepatocellular Carcinoma Cells. Srisa-Nga K; Mankhetkorn S; Okonogi S; Khonkarn R J Pharm Sci; 2019 Feb; 108(2):996-1006. PubMed ID: 30121312 [TBL] [Abstract][Full Text] [Related]
31. Enhanced Anti-tumor of Pep-1 Modified Superparamagnetic Iron Oxide/PTX Loaded Polymer Nanoparticles. Wang B; Wu W; Lu H; Wang Z; Xin H Front Pharmacol; 2018; 9():1556. PubMed ID: 30723412 [TBL] [Abstract][Full Text] [Related]
32. Targeting strategies for superparamagnetic iron oxide nanoparticles in cancer therapy. Zhi D; Yang T; Yang J; Fu S; Zhang S Acta Biomater; 2020 Jan; 102():13-34. PubMed ID: 31759124 [TBL] [Abstract][Full Text] [Related]
33. Development of a T Cell-targeted siRNA Delivery System Against HIV-1 Using Modified Superparamagnetic Iron Oxide Nanoparticles: An In Vitro Study. Kamalzare S; Iranpur Mobarakeh V; Mirzazadeh Tekie FS; Hajiramezanali M; Riazi-Rad F; Yoosefi S; Normohammadi Z; Irani S; Tavakoli M; Rahimi P; Atyabi F J Pharm Sci; 2022 May; 111(5):1463-1469. PubMed ID: 34673092 [TBL] [Abstract][Full Text] [Related]
34. Magnetic separation of encapsulated islet cells labeled with superparamagnetic iron oxide nano particles. Mettler E; Trenkler A; Feilen PJ; Wiegand F; Fottner C; Ehrhart F; Zimmermann H; Hwang YH; Lee DY; Fischer S; Schreiber LM; Weber MM Xenotransplantation; 2013; 20(4):219-26. PubMed ID: 23789985 [TBL] [Abstract][Full Text] [Related]
35. Surface engineering of iron oxide nanoparticles for targeted cancer therapy. Kievit FM; Zhang M Acc Chem Res; 2011 Oct; 44(10):853-62. PubMed ID: 21528865 [TBL] [Abstract][Full Text] [Related]
36. Preparation, Characterization, and In Vitro pH-sensitivity Evaluation of Superparamagnetic Iron Oxide Nanoparticle- Misonidazole pH-sensitive Liposomes. Li B; Li B; He D; Feng C; Luo Z; He M Curr Drug Deliv; 2019; 16(3):254-267. PubMed ID: 30426901 [TBL] [Abstract][Full Text] [Related]
37. Highly efficient magnetic stem cell labeling with citrate-coated superparamagnetic iron oxide nanoparticles for MRI tracking. Andreas K; Georgieva R; Ladwig M; Mueller S; Notter M; Sittinger M; Ringe J Biomaterials; 2012 Jun; 33(18):4515-25. PubMed ID: 22445482 [TBL] [Abstract][Full Text] [Related]
38. Biological impact of superparamagnetic iron oxide nanoparticles for magnetic particle imaging of head and neck cancer cells. Lindemann A; Lüdtke-Buzug K; Fräderich BM; Gräfe K; Pries R; Wollenberg B Int J Nanomedicine; 2014; 9():5025-40. PubMed ID: 25378928 [TBL] [Abstract][Full Text] [Related]
39. MR traceable delivery of p53 tumor suppressor gene by PEI-functionalized superparamagnetic iron oxide nanoparticles. Lee HJ; Nguyen YT; Muthiah M; Vu-Quang H; Namgung R; Kim WJ; Yu MK; Jon S; Lee IK; Jeong YY; Park IK J Biomed Nanotechnol; 2012 Jun; 8(3):361-71. PubMed ID: 22764405 [TBL] [Abstract][Full Text] [Related]
40. Differential effect of polyvinylpyrrolidone-coated superparamagnetic iron oxide nanoparticles on BT-474 human breast cancer cell viability. Aliakbari M; Mohammadian E; Esmaeili A; Pahlevanneshan Z Toxicol In Vitro; 2019 Feb; 54():114-122. PubMed ID: 30266435 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]